It is possible that a similar myeloproliferative phenotype would be detected with FBXO11 loss in the myeloid lineage, particularly if in the background of common MDS mutations, for example in TET2 and DNMT3A. This evidence concerns the gene FBXO11 and myelodysplastic syndrome.